Nanophase Technologies Corp
OTC:NANX
Nanophase Technologies Corp
Nanophase Technologies Corp. engages in the development and provision of engineered nanomaterial solutions. The company is headquartered in Romeoville, Illinois and currently employs 58 full-time employees. The Company’s product categories include personal care ingredients, advanced materials and Solesence. The firm offers soup-to-nuts production from engineered materials, formulation development, and finished product development to commercial manufacturing and packaging capabilities. Its capabilities in materials engineering allow it to coat and disperse materials on a nano and non-nano scale for use in a variety of markets in skin health, including for use in sunscreens as active pharmaceutical ingredients (APIs) and as fully developed skincare products, marketed and sold through its wholly owned subsidiary, Solesence, LLC. The firm has development and application laboratories and manufacturing capacity in over two locations in the Chicago, Illinois area.
Nanophase Technologies Corp. engages in the development and provision of engineered nanomaterial solutions. The company is headquartered in Romeoville, Illinois and currently employs 58 full-time employees. The Company’s product categories include personal care ingredients, advanced materials and Solesence. The firm offers soup-to-nuts production from engineered materials, formulation development, and finished product development to commercial manufacturing and packaging capabilities. Its capabilities in materials engineering allow it to coat and disperse materials on a nano and non-nano scale for use in a variety of markets in skin health, including for use in sunscreens as active pharmaceutical ingredients (APIs) and as fully developed skincare products, marketed and sold through its wholly owned subsidiary, Solesence, LLC. The firm has development and application laboratories and manufacturing capacity in over two locations in the Chicago, Illinois area.
This earnings call has not been analyzed yet.
If you’d like us to analyze this earnings call, click the "Request Earnings Call Analysis" button below.
